Maternal 25-hydroxyvitamin D is inversely correlated with foetal serotonin

Padma Murthi1,2, Miranda Davies-Tuck2,3, Martha Lappas4,5

  • 1Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Vic., Australia.

Clinical Endocrinology
|November 19, 2016
PubMed

Insights

Maternal vitamin D deficiency may increase fetal serotonin levels, potentially impacting infant neurodevelopment. This study found an inverse link between vitamin D and fetal serotonin, suggesting a mechanism for cognitive impairment.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Developmental Biology

Background:

  • Maternal vitamin D deficiency is linked to impaired childhood neurocognitive development.
  • The precise mechanism remains unclear but may involve serotonin, a key neurotransmitter in fetal brain development.

Purpose of the Study:

  • To investigate the association between maternal and fetal vitamin D levels and fetal serotonin concentrations.
  • To explore the role of vitamin D in regulating fetal serotonin.

Main Methods:

  • Measured serum 25-hydroxyvitamin D (25(OH)D) and serotonin (5-HT) in maternal and umbilical cord blood (n=64).
  • Utilized linear regression to analyze associations between vitamin D and serotonin.
  • Assessed the in vitro effects of vitamin D receptor (VDR) modulation on serotonin secretion in human umbilical vein endothelial cells (HUVECs).

Main Results:

  • An inverse relationship was observed between maternal and cord 25(OH)D concentrations and cord serotonin levels.
  • In vitro, 1,25-dihydroxyvitamin D3 treatment decreased serotonin release in HUVECs.
  • Inactivation of the VDR increased serotonin release in cultured HUVECs.

Conclusions:

  • This study provides the first evidence of an inverse relationship between maternal 25(OH)D and fetal serotonin.
  • Maternal vitamin D deficiency may lead to increased fetal serotonin, potentially contributing to neurocognitive impairments in infants and children.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
73.3K